|Princeton University, A.B.|
|Massachusetts Institute of Technolog, Ph.D.|
Anthony B. Evnin, Ph.D. has served as a director since March 2002.
He has been a Partner at Venrock, where he has focused largely on life sciences investments and, in particular, biotechnology investments, since 1975.
Dr. Evnin currently serves on the boards of Infinity Pharmaceuticals, Inc. and Pharmos Corporation as well as a number of private companies, including Acceleron Pharma Inc. and Metabolex, Inc.
Dr. Evnin is a Trustee of The Rockefeller University, a Trustee of The Jackson Laboratory, a Trustee Emeritus of Princeton University, and a Member of the Boards of Overseers and Managers of Memorial Sloan-Kettering Cancer Center.
Dr. Evnin holds a Ph.D. in Chemistry from the Massachusetts Institute of Technology and an A.B. from Princeton University.